Company news
Fluoropharma Medical Inc (OTC:FPMI) news
Fluoropharma Medical Inc news releases on 6ix. Latest, Oct 18, 2016: FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical…
Press releases & updates
FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial
October 18, 2016
FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting
September 28, 2016
FluoroPharma Medical Announces Details for Investor Call on June 22, 2016
June 17, 2016
FluoroPharma Announces a Letter of Intent to Acquire Ground Fluor Pharmaceuticals
June 9, 2016
FluoroPharma Enters Development and Commercialization Agreement for China and Canada
June 6, 2016
FluoroPharma Medical Announces Acceptance of CardioPET Data for Presentation at the 21st Scientific Meeting of the American Society of Nuclear Cardiology
May 25, 2016
FluoroPharma Medical Announces Details for Investor Call on January 6th
January 5, 2016
FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer
December 29, 2015
Cardiology Product Potential, Clinical Trial Progress and Capital Acquisition Success Drive the Company's Next Moves
October 23, 2015
Healthcare Industry Veteran, Thomas Tulip, Joins FluoroPharma Medical, Inc.
October 6, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – April 23
April 23, 2015